Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

1.

Impact of race, age, and socioeconomic status on participation in pancreatic cancer clinical trials.

El-Rayes BF, Jasti P, Severson RK, Almhanna K, Philip PA, Shields A, Zalupski M, Heilbrun LK.

Pancreas. 2010 Oct;39(7):967-71. doi: 10.1097/MPA.0b013e3181da91dd.

PMID:
20467351
[PubMed - indexed for MEDLINE]
2.

Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California.

Zell JA, Rhee JM, Ziogas A, Lipkin SM, Anton-Culver H.

Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):546-52.

PMID:
17372250
[PubMed - indexed for MEDLINE]
Free Article
3.

Risk of pancreatic adenocarcinoma: disparity between African Americans and other race/ethnic groups.

Chang KJ, Parasher G, Christie C, Largent J, Anton-Culver H.

Cancer. 2005 Jan 15;103(2):349-57.

PMID:
15593353
[PubMed - indexed for MEDLINE]
Free Article
4.

Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.

Albain KS, Unger JM, Crowley JJ, Coltman CA Jr, Hershman DL.

J Natl Cancer Inst. 2009 Jul 15;101(14):984-92. doi: 10.1093/jnci/djp175. Epub 2009 Jul 7.

PMID:
19584328
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study.

Advani AS, Atkeson B, Brown CL, Peterson BL, Fish L, Johnson JL, Gockerman JP, Gautier M.

Cancer. 2003 Mar 15;97(6):1499-506.

PMID:
12627515
[PubMed - indexed for MEDLINE]
Free Article
6.

The National Cancer Data Base report on pancreatic cancer.

Niederhuber JE, Brennan MF, Menck HR.

Cancer. 1995 Nov 1;76(9):1671-7.

PMID:
8635074
[PubMed - indexed for MEDLINE]
7.

Enrollment of African Americans onto clinical treatment trials: study design barriers.

Adams-Campbell LL, Ahaghotu C, Gaskins M, Dawkins FW, Smoot D, Polk OD, Gooding R, DeWitty RL.

J Clin Oncol. 2004 Feb 15;22(4):730-4.

PMID:
14966098
[PubMed - indexed for MEDLINE]
Free Article
8.

Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma.

Murphy MM, Simons JP, Ng SC, McDade TP, Smith JK, Shah SA, Zhou Z, Earle CC, Tseng JF.

Ann Surg Oncol. 2009 Nov;16(11):2968-77. doi: 10.1245/s10434-009-0656-5. Epub 2009 Aug 11.

PMID:
19669839
[PubMed - indexed for MEDLINE]
9.

The impact of socioeconomic status and race on trial participation for older women with breast cancer.

Gross CP, Filardo G, Mayne ST, Krumholz HM.

Cancer. 2005 Feb 1;103(3):483-91.

PMID:
15597407
[PubMed - indexed for MEDLINE]
Free Article
10.

Factors associated with enrollment of African Americans into a clinical trial: results from the African American study of kidney disease and hypertension.

Gadegbeku CA, Stillman PK, Huffman MD, Jackson JS, Kusek JW, Jamerson KA.

Contemp Clin Trials. 2008 Nov;29(6):837-42. doi: 10.1016/j.cct.2008.06.001. Epub 2008 Jun 27.

PMID:
18639652
[PubMed - indexed for MEDLINE]
Free PMC Article
11.
12.

Clinical trial participation. Viewpoints from racial/ethnic groups.

Roberson NL.

Cancer. 1994 Nov 1;74(9 Suppl):2687-91.

PMID:
7954287
[PubMed - indexed for MEDLINE]
13.

How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials.

Sateren WB, Trimble EL, Abrams J, Brawley O, Breen N, Ford L, McCabe M, Kaplan R, Smith M, Ungerleider R, Christian MC.

J Clin Oncol. 2002 Apr 15;20(8):2109-17.

PMID:
11956272
[PubMed - indexed for MEDLINE]
Free Article
14.

Cost-effectiveness and lung cancer clinical trials.

Du W, Reeves JH, Gadgeel S, Abrams J, Peters WP.

Cancer. 2003 Oct 1;98(7):1491-6.

PMID:
14508837
[PubMed - indexed for MEDLINE]
Free Article
15.

Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center.

Simon MS, Du W, Flaherty L, Philip PA, Lorusso P, Miree C, Smith D, Brown DR.

J Clin Oncol. 2004 Jun 1;22(11):2046-52. Epub 2004 Apr 13.

PMID:
15082724
[PubMed - indexed for MEDLINE]
Free Article
16.

African-American and low-socioeconomic status patients have a worse prognosis for invasive ductal and lobular breast carcinoma: do screening criteria need to change?

Yang R, Cheung MC, Franceschi D, Hurley J, Huang Y, Livingstone AS, Koniaris LG.

J Am Coll Surg. 2009 May;208(5):853-68; discussion 869-70. doi: 10.1016/j.jamcollsurg.2008.10.038. Epub 2009 Jan 21.

PMID:
19476849
[PubMed - indexed for MEDLINE]
17.

An examination of the influence of patient race and ethnicity on expressed interest in learning about cancer clinical trials.

Markman M, Petersen J, Montgomery R.

J Cancer Res Clin Oncol. 2008 Jan;134(1):115-8. Epub 2007 Jun 28.

PMID:
17598129
[PubMed - indexed for MEDLINE]
18.

Sociodemographic analysis of patients in radiation therapy oncology group clinical trials.

Chamberlain RM, Winter KA, Vijayakumar S, Porter AT, Roach M 3rd, Streeter O, Cox JD, Bondy ML.

Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):9-15.

PMID:
9422552
[PubMed - indexed for MEDLINE]
19.

Benefit of postoperative adjuvant therapy for pancreatic cancer: A population-based analysis.

Vanderveen KA, Chen SL, Yin D, Cress RD, Bold RJ.

Cancer. 2009 Jun 1;115(11):2420-9. doi: 10.1002/cncr.24269.

PMID:
19301434
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

[The prognostic factors of pancreatic cancer can be different according to clinical stages].

Kim YJ, Seo DW, Pack KM, Jeong E, Kim SC, Han DJ, Lee SS, Lee SK, Kim MH.

Korean J Gastroenterol. 2008 Mar;51(3):181-9.

PMID:
18451692
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk